Page 6 - Transcode Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TransCode Therapeutics Announces Closing of $7 25 Million Public Offering

BOSTON, Jan. 22, 2024 (GLOBE NEWSWIRE) TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the

New yorkUnited statesTom fitzgeraldHc wainwright coCompany annual report on formExchange commissionTranscode therapeutics incCode therapeuticsNasdaq capital marketMarket place ruleNasdaq listing ruleNote regarding forward lookingAnnual report

TransCode Therapeutics Announces Closing of $7 25 Million Public Offering

TransCode Therapeutics Announces Closing of $7 25 Million Public Offering
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesTom fitzgeraldExchange commissionTranscode therapeutics incHc wainwright coCompany annual report on formCode therapeutics announces closingCode therapeuticsNasdaq capital marketMarket place ruleNasdaq listing ruleNote regarding forward lookingAnnual report

TransCode Therapeutics Announces Pricing of $7 25 Million Public Offering - TransCode Therapeutics (NASDAQ:RNAZ)

BOSTON, Jan. 18, 2024 (GLOBE NEWSWIRE) TransCode Therapeutics, Inc. (NASDAQ:RNAZ) (the "Company"), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the

New yorkUnited statesTom fitzgeraldTranscode therapeutics incExchange commissionCompany annual report on formHc wainwright coCode therapeuticsNasdaq capital marketMarket place ruleNasdaq listing ruleNote regarding forward lookingAnnual report

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday s Mid-Day Session - Adagene (NASDAQ:ADAG), Absci (NASDAQ:ABSI)

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Mayank tandonEric sheridanAbsci corporationJames quigleyT incLithium americas corpVolato group incAlly financial incRobot corporationBullfrog ai holdings incGoldman sachsVision marine technologies incMesoblast limitedPortage biotech incUnited airlinesDatasea inc

TransCode Therapeutics (RNAZ) Prices 5 94M Share Offering at $1 22/sh

TransCode Therapeutics (RNAZ) Prices 5 94M Share Offering at $1 22/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesHc wainwright coExchange commissionTranscode therapeutics incTranscode therapeutics